Investigative Site

Rome 00161

0 studies enrolling now · 6 studies all time

What they study most

Diabetic Nephropathy, Familial Hypoalphalipoproteinemia, Hypertension, Obesity, Overweight

Studies at this site

• CER-001 Therapy as a Novel Approach to Treat Genetic Orphan Diseases — Stopped early
• Study of Gelesis100 on Body Weight in Overweight and Obese Subjects With and Without Type 2 Diabetes — Completed
• Safety and Efficacy of Aliskiren When Added to Standardized Losartan and Optimal Antihypertensive Therapy in Patients With Hypertension, Type 2 Diabetes and Proteinuria — Completed
• Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Amlodipine in Essential Hypertension — Completed
• Efficacy and Safety of the Combination Aliskiren (300 mg) and Hydrochlorothiazide (25mg) to Aliskiren (300mg) Monotherapy in Patients With Staged II Hypertension — Completed
• Efficacy and Safety of Aliskiren/Amlodipine/Hydrochlorothiazide in Patients With Moderate-severe Hypertension — Completed